This topic contains a solution. Click here to go to the answer

Author Question: Tim, a 27-year-old man, has unusually narrow shoulders, low muscle mass, and has no facial and body ... (Read 80 times)

cherise1989

  • Hero Member
  • *****
  • Posts: 555
Tim, a 27-year-old man, has unusually narrow shoulders, low muscle mass, and has no facial and body hair. His doctor recently prescribed testosterone replacement therapy to him. Tim is most likely suffering from:
 
  A) phenylketonuria (PKU).
  B) cystic fibrosis.
  C) Klinefelter syndrome.
  D) Huntington's disease (HD).

Question 2

Most American adolescents are unhealthy.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

eliasc0401

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

C

Answer to Question 2

False




cherise1989

  • Member
  • Posts: 555
Reply 2 on: Jun 22, 2018
Gracias!


komodo7

  • Member
  • Posts: 322
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

Though the United States has largely rejected the metric system, it is used for currency, as in 100 pennies = 1 dollar. Previously, the British currency system was used, with measurements such as 12 pence to the shilling, and 20 shillings to the pound.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library